The Market Reports

Synopsis

The global market for Scalp Vein Blood Collection Needle, Winged Needle, Butterfly Needle was estimated to be worth US$ 2267 million in 2024 and is forecast to a readjusted size of US$ 3633 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Scalp Vein Blood Collection Needle, Winged Needle, Butterfly Needle cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Scalp Vein Blood Collection Needle, Winged Needle or Butterfly Needle, is a specialized type of needle designed for the collection of blood samples or for intravenous (IV) access, particularly in small veins or difficult-to-reach areas. It features two flexible "wings" on either side of the needle, which allow for better grip and control during insertion, making it especially useful for patients with fragile veins, such as infants, the elderly, or those undergoing chemotherapy. The needle is often used for blood draws, IV fluid administration, or medication injections. Its design provides greater comfort and precision compared to standard needles, and it can be attached to a blood collection tube or syringe for easy sample collection. Due to its smaller size and design, it is less traumatic to veins, reducing the risk of complications like hematoma or vein rupture.In 2024, global Scalp Vein Blood Collection Needle, Winged Needle, Butterfly Needle production reached approximately 17462 million units, with an average global market price of around 129.8 USD/k unit.

The butterfly needle sector is driven by increasing prevalence of chronic diseases, growing demands for outpatient and home-based care, and heightened lab testing precision requirements. Enhanced regulatory oversight on infection control and occupational safety is accelerating adoption of safety-engineered butterfly needles. Leading companies, per their annual reports, are differentiating through ergonomic designs, lubricated surfaces, and innovative packaging, while expanding global footprints to tap into aging demographics and rising healthcare needs. Despite advantages in comfort and accuracy, butterfly needles face hurdles such as higher cost than conventional straight needles—limiting uptake in budget-constrained settings. Proper use depends heavily on clinician training, and lack thereof leads to higher failure or injury rates. Manufacturers also face diverse and evolving regulatory standards across markets, posing compliance challenges particularly for smaller producers. The downstream market is evolving from hospital-centric usage to diverse settings including home care, chronic disease management, and mobile healthcare. Demand for smaller gauge, safer, more patient-friendly butterfly needles is increasing, while integrated safety and one-stop blood collection systems are gaining traction. Manufacturers are innovating with user-oriented solutions tailored for home users and remote monitoring, deepening the integration of device and service ecosystems.

This report aims to provide a comprehensive presentation of the global market for Scalp Vein Blood Collection Needle, Winged Needle, Butterfly Needle, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Scalp Vein Blood Collection Needle, Winged Needle, Butterfly Needle by region & country, by Type, and by Application.

The Scalp Vein Blood Collection Needle, Winged Needle, Butterfly Needle market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Scalp Vein Blood Collection Needle, Winged Needle, Butterfly Needle.

Market Segmentation
By Company

• BD
• B. Braun
• Nipro
• Terumo
• WEGO Groupe
• Cardinal Health
• Greiner Bio One
• Sarstedt
• Berpu
• Sanli Medical
• ICU Medical
• Shanghai KDL
• Improve Medical
• QIAO PAI
• Kangjian Medical
• Shangdong AOSAITE
• Jichun
• Zibo Shanchuan

Segment by Type

• Ordinary Needle
• Safety Needle

Segment by Application

• Hospital
• Clinic
• Other

Segment by Region

• North America: United States, Canada, and Mexico
• Europe: United Kingdom, Germany, France, Spain, Italy, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, and Rest of Asia Pacific
• Middle East & Africa: Saudi Arabia, South Africa, and Rest of MEA
• Latin America: Brazil, Argentina, and Rest of Latin America

*If you need a regional or country-specific version, or customized segmentation, we can tailor the report to your requirements.